Primary and secondary uraemic hyperparathyroidism: From initial clinical observations to recent findings

Nephrology Dialysis Transplantation

Volumn 13, Issue 6, 1998, Pages 1384-1387

  Drüeke, Tilman B ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Hyperparathyroidism; Primary; Secondary

Indexed keywords

PARATHYROID HORMONE; CALCITONIN; CALCITRIOL; CALCIUM; PHOSPHATE; TRANSFORMING GROWTH FACTOR ALPHA;

CLINICAL FEATURE; HORMONE ACTION; HUMAN; PARATHYROID HORMONE RELEASE; PARATHYROID HYPERPLASIA; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; SECONDARY HYPERPARATHYROIDISM; SHORT SURVEY; ARTICLE; CHRONIC KIDNEY FAILURE; GENE MUTATION; HYPERPARATHYROIDISM; INCIDENCE; NONHUMAN; PARATHYROID ADENOMA; PATHOPHYSIOLOGY; PRIMARY UREMIC HYPERPARATHYROIDISM; RADIOIMMUNOASSAY; RISK FACTOR; SECONDARY UREMIC HYPERPARATHYROIDISM; UREMIA;

HUMANS; HYPERPARATHYROIDISM; HYPERPARATHYROIDISM, SECONDARY; HYPERPLASIA; PARATHYROID GLANDS; PARATHYROID HORMONE; UREMIA;

EID: 0031779891     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/13.6.1384     Document Type: Short Survey

References (42)

1. Mandl F. Therapeutischer Versuch bei Ostitis fibrosa generalisata mittels Extirpation eines Epithelkoerperchentumors. Wien Klin Wochenschr 1925; 50: 1343-1344
2. Albright F, Aub JC, Bauer W. Hyperparathyroidism common and polymorphic condition as illustrated by 17 proved cases from one clinic. J Am Med Assoc 1934; 102: 1276-1287
3. McGeown MG, Morrison E. Hyperparathyroidism. Postgrad Med J 1959; 35: 330-337
4. Melton-III LJ. Epidemiology of primary hyperparathyroidism. J Bone Min Res 1991; 6 [suppl 2]: S25-S30
5. Thomson D, Collip JB. The parathyroid glands. Physiol Rev 1932; 12: 209
6. Jaffe HL. Hyperparathyroidism (Recklinghausen's disease of bone). Arch Pathol 1933; 16: 63-112 and 236-258
7. Albright F, Ellsworth RJ. Studies on the physiology of the parathyroid glands. J Clin Invest 1929; 7: 183-201
8. Stewart GS, Bowen HF. The parathyroid control of serum calcium independent of renal metabolism. Endocrinology 1951; 48: 568-575
9. McGeown MG. Gastric function in primary hyperparathyroidism in man. Irish J Med Sci 1975; 144: 217-226
10. Jüppner H, Abou-Samra AB, Freeman MW et al. A G proteinlinked receptor for parathyroid hormone and parathyroid hormone-related peptide. Science 1991; 254: 1024-1026
11. Ureña P, Lee K, Weaver D, et al. PTH/PTHrP receptor mRNA expression as assessed by Northern blot and in situ hybridization. J Bone Min Res 1992; 7: S118
12. Broadus AE, Horst RL, Lang R. The importance of circulating 1,25 dihydroxy vitamin D in the pathogenesis of hypercalciuria and renal stone formation in primary hyperparathyroidism. N Engl J Med 1980; 302: 421-425
13. Patron P, Gardin JP, Paillard M. Renal mass and reserve of vitamin D: determinants in primary hyperparathyroidism. Kidney Int 1987; 31: 1176-1180
14. Pak CY, Nicar MJ, Peterson R. A lack of unique pathophysiologic background for nephrolithiasis of primary hyperparathyroidism. J Clin Endocrinol Metab 1981; 53: 536-542
15. McGeown MG. Human calcitonin, serum phosphate, renal failure. Lancet 1974; i: 813-814
16. McGeown MG. Calcium and phosphorus in the diagnosis of hyperparathyroidism. Urol Int 1965; 19: 83-92
17. Silver J. What stimuli control the activity of the parathyroid cell? Nephrol Dial Transplant 1995; 10: 599-600
18. Almadén Y, Canalejo A, Hernandez A, et al. Direct effect of phosphorus on parathyroid hormone secretion from whole rat parathyroid glands in vitro. J Bone Min Res 1996; 11: 970-976
19. Nielsen PK, Feldt-Rasmussen U, Olgaard K. A direct effect of phosphate on PTH release from bovine parathyroid tissue slices but not from dispersed parathyroid cells. Nephrol Dial Transplant 1996; 11: 1762-1768
20. Slatopolsky E, Finch J, Denda M et al. Phosphorus restriction prevents parathyroid gland growth: high phosphorus directly stimulates PTH secretion in vitro. J Clin Invest 1996; 97: 2534-2540
21. 2+ by parathyroid and kidney cells. Eur J Endocrinol 1995; 132: 523-531
22. Samuels MH, Veldhuis JD, Cawley C, et al. Pulsatile secretion of parathyroid hormone in normal young subjects: assessment by deconvolution analysis. J Clin Endocrinol Metab 1993; 77: 399-403
23. Schmidt CP, Schaefer F, Bruch A et al. Control of pulsatile and tonic parathyroid hormone secretion by ionized calcium. J Clin Endocrinol Metab 1996; 81: 4236-4243
24. 3 reduces spontaneous and hypocalcemia stimulated pulsatile component of parathyroid hormone secretion. J Am Soc Nephrol 1998; 9: 54-62
25. Arnold A, Staunton CE, Kim HG, Gaz RD, Kronenberg HM. Monoclonality and abnormal parathyroid hormone genes in parathyroid adenomas. N Engl J Med 1988; 318: 658-662
26. Arnold A, Brown MF, Ureña P, Gaz RD, Sarfati E, Drüeke TB. Monoclonality of parathyroid tumors in chronic renal failure and in primary parathyroid hyperplasia. J Clin Invest 1995; 95: 2047-2054
27. Cryns VL, Yi SM, Tahara H, Gaz RD, Arnold A. Frequent loss of chromosome arm Ip DNA in parathyroid adenomas. Gene Chromosome Cancer 1995; 13: 9-17
28. Arnold A, Kim HG, Gaz RD et al. Molecular cloning and chromosome mapping of DNA rearranged with the parathyroid hormone gene in parathyroid adenoma. J Clin Invest 1989; 83: 2034-2040
29. Tahara H, Smith AP, Gaz RD, Cryns VL, Arnold A. Genomic localization of novel candidate tumor suppressor gene loci in human parathyroid adenomas. Cancer Res 1996; 56: 599-605
30. Chandrasekharappa SC, Guru SC, Manickam P et al. Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 1997; 276: 404-407
31. Mulligan LM, Kwok JBJ, Healy CS. Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 1993; 363: 458-460
32. Cryns VL, Thor A, Xu HJ et al. Loss of retinoblastoma tumorsuppressor gene in parathyroid carcinoma. N Engl J Med 1994; 330: 757-761
33. Fukuda N, Tanaka H, Tominaga Y, Fukagawa M, Kurokawa K, Seino Y. Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients. J Clin Invest 1993; 92: 1436-1442
34. Kifor O, Moore FD, Wang P et al. Reduced immunostaining for the extracellular Ca2+ - sensing receptor in primary and uremic secondary hyperparathyroidism. J Clin Endocrinol Metab 1996; 81: 1598-1606
35. Gogusev J, Duchambon P, Hory B, Giovannini M, Sarfati E, Drüeke TB. Depressed expression of calcium receptor in parathyroid gland tissue of patients with primary or secondary uremic hyperparathyroidism. Kidney Int 1997; 51: 328-336
36. Gogusev J, Duchambon P, Stoermann-Chopard C, Giovannini M, Sarfati E, Drüeke TB. De novo expression of transforming growth factor-α in parathyroid gland tissue of patients with primary or secondary uraemic hyperparathyroidism. Nephrol Dial Transplant 1996; 11: 2155-2162
37. Tominaga Y, Kohara S, Namii Y et al. Clonal analysis of nodular parathyroid hyperplasia in renal hyperparathyroidism. World J Surg 1996; 20: 744-752
38. Drüeke T. The pathogenesis of parathyroid gland hyperplasia in chronic renal failure (Nephrology Forum). Kidney Int 1995; 48: 259-272
39. Inagaki C, Dousseau M, Pacher N, Sarfati E, Drücke TB, Gogusev J. Structural analysis of gene marker loci on chromosomes 10 and 11 in primary and secondary uraemic hyperparathyroidism. Nephrol Dial Transplant 1998; 13: 350-357
40. Falchetti A, Bale AE, Amorosi A et al. Progression of uremic hyperparathyroidism involves allelic loss on chromosome 11. J Clin Endocrinol Metab 1993; 76: 139-144
41. Drücke TB, Zhang P, Gogusev J. Apoptosis: background and possible role in secondary hyperparathyroidism (Invited Comment). Nephrol Dial Transplant 1997; 12: 2228-2233
42. Drüeke T, Duchambon P, Gogusev J, Sarfati E, Bourdeau A. Reassessment of apoptosis in patients with primary (I°) and uraemic secondary (II°) hyperparathyroidism (HPTH) (Abstract). Nephrol Dial Transplant 1998 (in press)